Nerve Growth Factor Eye Drops Show Four-Year Safety in Children With Optic Pathway Gliomas
A four-year observational follow-up of children treated with nerve growth factor eye drops in a randomized phase II trial shows ...
A four-year observational follow-up of children treated with nerve growth factor eye drops in a randomized phase II trial shows ...
A new study identifies the frataxin gene FXN as a diagnostic biomarker for primary open-angle glaucoma and shows that the ...
New research in Cell Death Discovery shows that recombinant human nerve growth factor protects retinal ganglion cells in a glaucoma ...
Aarhus University researchers have created injectable graphitic carbon nitride nanoparticles that make degenerated retinas respond to light, offering a promising ...
A new Gene Therapy review charts how mutation-agnostic optogenetic gene therapy could restore vision in blind patients, while detailing the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine